Study introduces mRNA-LNP as a safe therapeutic intervention for liver regeneration
When severely or chronically injured, the liver loses its ability to regenerate.
Jan 27, 2021
0
37
When severely or chronically injured, the liver loses its ability to regenerate.
Jan 27, 2021
0
37
Hepatocellular carcinoma (HCC), frequently seen in patients with liver cirrhosis caused by alcohol abuse or chronic viral hepatitis, is the most common form of liver cancer worldwide. As such, it is the third-most common ...
Jan 6, 2021
0
4
Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month. From the beginning, most scientists have said that COVID-19 is deadlier ...
Dec 16, 2020
0
75
U.S. regulators Wednesday approved the first drug for the treatment of Ebola.
Oct 15, 2020
0
9
An affordable anti-microbial drug used to treat stomach ulcers and bacterial infections has shown promise in combatting the coronavirus in animals, scientists in Hong Kong announced Monday.
Oct 12, 2020
0
288
Researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have recently conducted a study to investigate the impact of liver injury on clinical outcomes in COVID-19 patients. Data from ...
Aug 6, 2020
0
2
With the number of liver transplants performed at the University of Chicago Medicine on track to reach a 20-year high, a new study by the institution's researchers reinforces the growing popularity and safety of using livers ...
Jul 23, 2020
0
1
Brazil's health ministry recommended Wednesday using chloroquine and hydroxychloroquine to treat even mild cases of COVID-19, treatments President Jair Bolsonaro has pushed for despite a lack of conclusive evidence of their ...
May 20, 2020
0
12
Researchers from the Faculty of Medicine of the University of Barcelona and the CELLEX Biomedical Research Centre from IDIBAPS, in collaboration with scientists from the University of Sydney, University of London and the ...
May 6, 2020
0
32
A new study by researchers in the Quadram Institute has provided insights into how interactions between gut microbes and cells of the immune system contribute to cholestatic liver disease.
Apr 20, 2020
0
19